Published in Breast Cancer Res Treat on November 01, 2005
Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell (2008) 2.65
Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials. Mol Cancer Ther (2008) 1.88
Targeting insulin-like growth factor pathways. Br J Cancer (2006) 1.57
A Comprehensive Spectroscopic and Computational Investigation to Probe the Interaction of Antineoplastic Drug Nordihydroguaiaretic Acid with Serum Albumins. PLoS One (2016) 1.39
IGF-1R as an anti-cancer target--trials and tribulations. Chin J Cancer (2013) 1.31
Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach. J Med Chem (2009) 1.10
Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms. Oncotarget (2013) 1.04
The insulin receptor: a new target for cancer therapy. Front Endocrinol (Lausanne) (2011) 0.99
Nordihydroguaiaretic acid inhibits an activated fibroblast growth factor receptor 3 mutant and blocks downstream signaling in multiple myeloma cells. Cancer Res (2008) 0.93
Progress of molecular targeted therapies for prostate cancers. Biochim Biophys Acta (2011) 0.89
Inhibition of IGF-1R and lipoxygenase by nordihydroguaiaretic acid (NDGA) analogs. Bioorg Med Chem Lett (2007) 0.88
Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells. J Cell Biochem (2007) 0.86
Regulation of pro-inflammatory responses by lipoxygenases via intracellular reactive oxygen species in vitro and in vivo. Exp Mol Med (2008) 0.85
Discovery of novel non-ATP competitive FGFR1 inhibitors and evaluation of their anti-tumor activity in non-small cell lung cancer in vitro and in vivo. Oncotarget (2014) 0.83
Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside. Cancer Prev Res (Phila) (2010) 0.82
Nordihydroguaiaretic Acid Extends the Lifespan of Drosophila and Mice, Increases Mortality-Related Tumors and Hemorrhagic Diathesis, and Alters Energy Homeostasis in Mice. J Gerontol A Biol Sci Med Sci (2014) 0.79
Nordihydroguaiaretic acid inhibits transforming growth factor beta type 1 receptor activity and downstream signaling. Eur J Pharmacol (2009) 0.78
IGF-IR and its inhibitors in gastrointestinal carcinomas (Review). Oncol Lett (2010) 0.75
Nordihydroguaiaretic acid impairs prostate cancer cell migration and tumor metastasis by suppressing neuropilin 1. Oncotarget (2016) 0.75
Overcoming trastuzumab resistance with nordihydroguaiaretic acid? Breast Cancer Res Treat (2005) 0.75
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol (2009) 8.65
Assessment of genome-wide protein function classification for Drosophila melanogaster. Genome Res (2003) 8.39
Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity (2008) 6.08
Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev (2002) 6.05
Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet (2005) 4.44
Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes (2003) 4.40
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc Natl Acad Sci U S A (2011) 3.23
Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family. Immunol Rev (2011) 2.54
The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal (2005) 2.46
T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc Natl Acad Sci U S A (2003) 2.34
Breast cancer growth prevention by statins. Cancer Res (2006) 2.09
Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA (2011) 2.00
Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. BMJ (2008) 1.96
Genomic diversity and evolution of the head crest in the rock pigeon. Science (2013) 1.68
Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab (2002) 1.67
Genome of the long-living sacred lotus (Nelumbo nucifera Gaertn.). Genome Biol (2013) 1.59
A blueprint for telerehabilitation guidelines--October 2010. Telemed J E Health (2011) 1.54
IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance. Diabetes Care (2006) 1.52
The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev (2008) 1.52
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat (2010) 1.42
Production of α-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biol (2013) 1.42
Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance. Diabetes (2005) 1.24
Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience. Diabetes Care (2012) 1.19
Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev (2007) 1.19
Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis. Traffic (2013) 1.14
Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia. Am J Physiol Endocrinol Metab (2005) 1.14
Geographical and organisational variation in the structure of primary care services: implications for study design. J Health Serv Res Policy (2003) 1.11
Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Mol Cancer Ther (2006) 1.02
Reduction of MTT by aqueous herbal extracts in the absence of cells. J Ethnopharmacol (2004) 1.01
A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic control. Diabetes (2012) 1.01
A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes. J Clin Oncol (2006) 0.99
Insulin and hybrid insulin/IGF receptors are major regulators of breast cancer cells. Breast Dis (2003) 0.99
Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines. Thyroid (2005) 0.99
Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T. Magn Reson Imaging (2007) 0.98
Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle. PLoS One (2011) 0.97
Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic esophagitis. Allergy Asthma Clin Immunol (2010) 0.97
Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer. Urol Oncol (2007) 0.97
Discovery and structure-activity relationships of pyrrolone antimalarials. J Med Chem (2013) 0.95
Two analogues of fenarimol show curative activity in an experimental model of Chagas disease. J Med Chem (2013) 0.94
The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines. J Clin Endocrinol Metab (2003) 0.94
Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse. In Vitro Cell Dev Biol Anim (2002) 0.94
A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci Rep (2013) 0.90
Regulation of insulin receptor function by a small molecule insulin receptor activator. J Biol Chem (2002) 0.90
Influence of gender on the relationship between insulin sensitivity, adiposity, and plasma lipids in lean nondiabetic subjects. Metabolism (2009) 0.89
Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells. J Cell Biochem (2008) 0.89
Mechanisms of action of novel skin penetration enhancers: phospholipid versus skin lipid liposomes. Int J Pharm (2005) 0.88
Inhibition of IGF-1R and lipoxygenase by nordihydroguaiaretic acid (NDGA) analogs. Bioorg Med Chem Lett (2007) 0.88
A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer. BJU Int (2008) 0.88
Soliciting kidneys on web sites: is it fair? Semin Dial (2006) 0.87
Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells. J Cell Biochem (2007) 0.86
Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans. Brain Res Bull (2009) 0.86
Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta. Curr Diabetes Rev (2005) 0.86
How spectroscopic x-ray imaging benefits from inter-pixel communication. Phys Med Biol (2014) 0.86
Misdiagnosis of α-1 antitrypsin phenotype in an infant with CMV infection and liver failure. Dig Dis Sci (2014) 0.86
Increased HLA-DR expression on tissue eosinophils in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2010) 0.86
Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid. Endocr Pract (2002) 0.85
Gender differences in the relationship of ENPP1/PC-1 variants to obesity in a Turkish population. Obesity (Silver Spring) (2008) 0.85
Parallel synthesis of diarylureas and their evaluation as inhibitors of insulin-like growth factor receptor. J Comb Chem (2006) 0.84
Evidence that an HMGA1 gene variant associates with type 2 diabetes, body mass index, and high-density lipoprotein cholesterol in a Hispanic-American population. Metab Syndr Relat Disord (2013) 0.83
Chapter 13 The linkage of incident renal replacement therapy patients in England (2002-2006) to hospital episodes and national mortality data: improved demography and hospitalisation data in patients undergoing renal replacement therapy. Nephron Clin Pract (2012) 0.83
Comment on: Marquez et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 2012;61:524-530. Diabetes (2012) 0.83
Survival statistics. Br J Gen Pract (2007) 0.82
5-2-1-almost none: parents' perceptions of changing health-related behaviors in their obese child. Perm J (2009) 0.82
Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties. J Pharmacol Exp Ther (2013) 0.81
Genetic variants of the ENPP1/PC-1 gene are associated with hypertriglyceridemia in male subjects. Metab Syndr Relat Disord (2009) 0.81
Hodgkin lymphoma following adalimumab for the treatment of Crohn's disease in an adolescent. Dig Dis Sci (2014) 0.80
Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesions. Antiviral Res (2011) 0.80
Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial. Br J Psychiatry (2006) 0.79
In vitro and in vivo prevention of HIV protease inhibitor-induced insulin resistance by a novel small molecule insulin receptor activator. J Cell Biochem (2004) 0.79
Multiple introductions boosted genetic diversity in the invasive range of black cherry (Prunus serotina; Rosaceae). Ann Bot (2010) 0.79
Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells. Prostate (2008) 0.79
Effective treatments for insulin resistance: trim the fat and douse the fire. Trends Endocrinol Metab (2004) 0.79
Analysis of insulin-stimulated insulin receptor activation and glucose transport in cultured skeletal muscle cells from obese subjects. Metabolism (2005) 0.79
Grating-based x-ray phase-contrast imaging with a multi energy-channel photon-counting pixel detector. Opt Express (2013) 0.78
Modulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by chemotherapy in thyroid cancer cell lines. Thyroid (2003) 0.78
Aging and insulin resistance: just say iNOS. Diabetes (2013) 0.78